BiondVax Pharmaceuticals Ltd. - American Depositary Shares (BVXV)
BVXV moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How BVXV actually reacts to news — the realized, point-in-time move the market made, measured across 592 labeled events over its full measured history with zero look-ahead.
BVXV’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 29% | 461 |
| 30-min | 0.00% | 38% | 507 |
| 60-min | 0.00% | 42% | 516 |
| to close | 0.00% | 48% | 532 |
| Middle 50% of BVXV reactions | -1.50% to +0.95% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 592 |
Half of all BiondVax Pharmaceuticals Ltd. - American Depositary Shares news events land between -1.50% and +0.95% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BVXV moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BVXV's baseline. Nothing else.
Recent BVXV events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 20-F Scinai Immunotherapeutic For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: May 15 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: May 07 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form NT 20-F Scinai Immunotherapeutic For: Dec 31 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Apr 25 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Apr 16 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG | Press release | PR Newswire | — | — | |
| Scinai leadership to attend BIO-Europe Spring 2024 | Press release | PR Newswire | — | — | |
| Form EFFECT Scinai Immunotherapeutic | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Scinai Welcomes Liat Halpert as Head of Business Development and Sales | Press release | PR Newswire | — | — | |
| Form F-3 Scinai Immunotherapeutic | SEC filing · Form F-3 | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Jan 18 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form D Scinai Immunotherapeutic | SEC filing · Form D | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Jan 09 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Jan 04 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds | Press release | PR Newswire | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Jan 02 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form EFFECT Scinai Immunotherapeutic | SEC filing · Form EFFECT | SEC EDGAR | — | — | |
| Form F-1/A Scinai Immunotherapeutic | SEC filing · Form F-1 | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Dec 14 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Nov 20 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule | Press release | PR Newswire | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Nov 13 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Nov 07 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Nov 03 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form 6-K Scinai Immunotherapeutic For: Nov 02 | SEC filing · Form 6-K | SEC EDGAR | — | — | |
| Form F-1 Scinai Immunotherapeutic | SEC filing · Form F-1 | SEC EDGAR | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BVXV section they belong to.
Where else BVXV is measured.
BVXV earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OXFORD IMMUNOTEC GLOBAL PLC OR (OXFD) | 601 | -0.07% | 43% |
| MARIJUANA CO OF AMER INC (MCOA) | 597 | 0.00% | 39% |
| EGALET CORP COMMON (EGLT) | 591 | -0.21% | 40% |
| Amgen Inc. (AMGN) | 590 | +0.12% | 59% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is BiondVax Pharmaceuticals Ltd. - American Depositary Shares's median reaction calculated?
Every labeled BVXV news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 592 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of BVXV's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BVXV's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.